Elizabeth Holmes living on Green Gables estate while on trial for fraud

Former Theranos CEO and her husband, Billy Evans, are living in a home on the 74-acre property listed for $135M

Elizabeth Holmes and the home (Getty, Christie's Real Estate)
Elizabeth Holmes and the home (Getty, Christie's Real Estate)

Elizabeth Holmes, the former Theranos CEO now awaiting trial on wire fraud charges, is living in a home on the storied 74-acre Green Gables estate in Woodside.

Built in 1911 by San Francisco banker and businessman Mortimer Fleishhacker, Green Gables features one main house and six “more modest” homes, one of which Holmes and her husband, Billy Evans, now occupy, CNBC reported. The entire estate is listed for sale at $135 million.

The estate is 25 miles from the San Jose federal courthouse where Holmes is standing trial on multiple charges of wire fraud and conspiracy to commit wire fraud for distributing falsified blood tests. Opening statements in Holmes’ trial begin this week.

The area is home to Silicon Valley elite including billionaires Charles Schwab, Gordon Moore, Larry Ellison and John Doerr. One local business owner in nearby Woodside described Green Gables to CNBC as a place “where people go to lay low.”

Sign Up for the undefined Newsletter

The estate, which has hosted royalty and political elite, was also the site of the United Nations 20th anniversary gala in 1965. The 10,000-square-foot main house has nine bedrooms and a game room with “extensive paneling depicting the four corners of the world,” according to the listing, which is being handled by Christie’s International Real Estate and Compass Real Estate.

The grounds feature three swimming pools, including one stadium-sized Roman-style pool, a tennis court, orchards and vegetable and flower gardens. Of the six additional homes, four of them can be rented out on a yearly basis.

Forbes dubbed Holmes the “world’s youngest self-made female billionaire” in 2015. Not long after that, a series of reports by former Wall Street Journal reporter John Carreyrou showed the company’s blood-testing technology didn’t work.

Read more

[CNBC] — Victoria Pruitt